FDA Approved: ZIPRASIDONE MESYLATE — Supplemental Application (Fosun Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for ziprasidone mesylate, a salt form of ziprasidone, submitted by Fosun Pharma USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Ziprasidone mesylate (Ziprasidone mesylate)

Snippet

SUPPL AP for ZIPRASIDONE MESYLATE (ZIPRASIDONE MESYLATE)